Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Influence of Opioid Analgesia on Circulating Tumor Cells in Open Colorectal Cancer Surgery

ABSTRACT: To compare the effects of three types of perioperative analgesia on the number of circulating tumor cells following radical colorectal cancer surgery. To find correlations with other perioperative factors and clinical/pathological disease characteristics.

DISEASE(S): Neoplastic Cells, Circulating,Colorectal Cancer,Colorectal Neoplasms,Circulating Tumor Cell

PROVIDER: 2286388 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Influence of Opioid Analgesia on Circulating Tumor Cells in Laparoscopic Colorectal Cancer Surgery

Project description:To compare the effects of three types of perioperative analgesia on the number of circulating tumor cells following radical colorectal cancer surgery. To find correlations with other perioperative factors and clinical/pathological disease characteristics.

| 2286398 | ecrin-mdr-crc

Mimicking opioid analgesia in cortical pain circuits

Project description:Mimicking opioid analgesia in cortical pain circuits

| PRJNA1330160 | ENA

A mu opioid receptor superagonist that produces analgesia with minimal adverse effects

Project description:Developing safe and effective pain medications is an ongoing challenge for human health. Mu opioid receptor (MOR) agonists are essential pain medications, but their high intrinsic efficacy induces adverse side effects, including respiratory depression, constipation, tolerance, dependence, withdrawal, and addiction. Strategies to limit such effects traditionally include developing MOR agonists that have low intrinsic efficacy or preferentially activate G protein over β-arrestin signaling. We report the discovery of a novel MOR superagonist with supraphysiological intrinsic efficacy and a unique pharmacological profile that produces effective analgesia in rodents with minimal adverse side effects. N-desethyl-fluornitrazene (DFNZ) was derived from a class of synthetic benzimidazole opioids called Nitazenes. DFNZ has a unique spatiotemporal MOR cellular signaling profile that favors G protein activation over β-arrestin recruitment, impaired brain penetrance, and diminished efficacy at the MOR-galanin 1 receptor (Gal1R) heteromer. DFNZ does not induce respiratory depression, tolerance, or MOR desensitization after repeated exposure. Compared to other MOR agonists, DFNZ does not increase dopamine transmission in nucleus accumbens and has weaker reinforcing effects in the drug self-administration procedure. These results provide novel insights on MOR pharmacology, have important implications for pain and addiction treatment, and challenge the prevailing dogma that MOR superagonists cannot constitute safe and effective therapeutics.

2026-05-25 | PXD062863 | Pride

Runx1 transcriptional regulation of microglia critically modulates opioid analgesia and withdrawal in humans and rodents [ChIP-seq]

Project description:Opioid pain-relief and adverse outcomes differ between individuals. We show that runt-related transcription factor 1 (Runx1) is a determinant of opioid responses in humans and rodents and modulates the microglial transcriptome. Electron microscopy and single-cell RNA-sequencing revealed that deletion of Runx1 from microglia produces distinct ultra-structural and transcriptomic signatures. Microglia Runx1-deficient mice have reduced morphine potency, despite having no prior opioid exposure and normal nociceptive thresholds. These mice required greater amounts of post-operative morphine and displayed robust morphine-induced hyperalgesia and exacerbated withdrawal. In humans, genome-wide linkage analyses (GWAS) revealed variations within the Runx1 gene is associated with inter-individual differences in perioperative opioid requirement and opioid withdrawal severity. Identification of Runx1 susceptibility genotypes has implications for individualizing opioid pain management and determining risk of opioid dependence.

2026-01-30 | GSE253851 | GEO

Research on the Application of Lubricated Catheters in Perioperative Mucosal Analgesia and Comfortable Medical Care

Project description:Research on the Application of Lubricated Catheters in Perioperative Mucosal Analgesia and Comfortable Medical Care

| PRJNA1284904 | ENA

Brain and Genetic Predictors of Placebo Analgesia

Project description:Brain and Genetic Predictors of Placebo Analgesia

| PRJNA671312 | ENA

Brain and Genetic Predictors of Placebo Analgesia

Project description:Brain and Genetic Predictors of Placebo Analgesia

| PRJNA671307 | ENA

Research on the Application of Lubricated Catheters in Perioperative Mucosal Analgesia and Comfortable Medical Care

Project description:This study aims to investigate the improving effects of lubricated catheters on mucosal injuries and complications associated with perioperative endotracheal intubation.

2026-07-08 | GSE301389 | GEO

Mimicking opioid analgesia in cortical pain circuits

Project description:We performed single nuclei transcriptomics on the anterior cingulate cortex of mice cohorts that received either neuropathic pain (sciatic nerve injury) or sham surgery, followed by varying posto-injury periods (3 days, 3 weeks, or 3 months). Five minutes prior to tissue collection, pain active genes were stimulated via one second static fiber (0.16g) to each hind paw (1x/30sec/5min).

2026-01-09 | GSE308301 | GEO

Runx1 transcriptional regulation of microglia critically modulates opioid analgesia and withdrawal in humans and rodents

Project description:Runx1 transcriptional regulation of microglia critically modulates opioid analgesia and withdrawal in humans and rodents

| PRJNA1067560 | ENA